Study of effects of metformin on C-reactive protein level in Type-2 diabetes mellitus
نویسندگان
چکیده
منابع مشابه
prevalence of atopic dermatitis in children with type 1 diabetes mellitus in southeastern of iran (kerman province): a case-control study
چکیده ندارد.
15 صفحه اولEVALUATION OF SERUM CHITINASE-3 LIKE 1 PROTEIN AND C-REACTIVE PROTEIN LEVELS IN TYPE 2 DIABETES MELLITUS WITH CORONARY ARTERY DISEASE COMPARED TO DIABETIC AND HEALTHY CONTROL
Background: Diabetes mellitus, which is associated with elevated blood glucose, lipids and liver enzymes, may results in alterations in the production of inflammatory cytokines, including chitinase-3-like protein 1 (YKL-40) and high-sensitivity C-reactive protein (hs-CRP), which induce and promote complications of diabetes such as atherosclerosis.The aim of this study was to evaluate the serum ...
متن کاملStudy effects of Staphylococcus aureus superantigen C on production of C- reactive protein in rat
Background and purpose: Recently, microbial super antigens have been reported in blood and synovial fluid of rheumatoid arthritis patients. Whether or not, the presence of these super antigens could provoke the induction of serologic diagnostic factors, including CrP in patients? the purpose of this study was to production and purification one of the super antigen C of Staphylococcus aureus and...
متن کاملSerum High Sensitive - C Reactive Protein Levels in Type 2 Diabetes Mellitus -A Case Control Study
Background: The process of inflammation induces hepatic synthesis of various acute phase proteins such as high sensitivity C-reactive protein (hs-CRP) which is believed to play a role in insulin resistance. Higher incidence of type-2 diabetes mellitus has been observed with high levels of hs-CRP. Objectives: The present case control study was under taken to 1. Find the serum hs-CRP levels in ty...
متن کاملEffects of bromocriptine mesylate on homocysteine and high-sensitivity C-reactive protein levels in patients with type-2 diabetes mellitus
INTRODUCTION Quick release bromocriptine (BROM-QR), currently approved for glycemic control, reduces the risk of cardiovascular events in adults with type-2 diabetes mellitus (T2DM). This study evaluates the effect of BROM-QR on homocysteine (HOMC) and high sensitive C-reactive protein (hs-CRP), the biochemical markers of coronary atherosclerosis/inflammation, in patients with uncontrolled T2DM...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Basic & Clinical Pharmacology
سال: 2015
ISSN: 2319-2003
DOI: 10.5455/2319-2003.ijbcp20150205